يعرض 1 - 10 نتائج من 146 نتيجة بحث عن '"Van Nueten, Luc"', وقت الاستعلام: 1.07s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Department of Neurosciences, University of Helsinki, Geriatrian yksikkö, Helsinki University Hospital Area

    وصف الملف: application/pdf

    العلاقة: We would like to acknowledge Marita Parviainen, RN, for assistance and cognitive testing. The study was funded by Janssen R-D, a division of Janssen Pharmaceutica NV, Kuopio University Hospital VTR (#5252614) fund and Sigrid Juselius Foundation. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017-00915), the Alz-heimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615), the Swedish Alzhei-mer Foundation (#AF-742881), Hj?rnfonden, Sweden (#FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236). We would like to acknowledge Marita Parviainen, RN, for assistance and cognitive testing. The study was funded by Janssen R&D, a division of Janssen Pharmaceutica NV, Kuopio University Hospital VTR (#5252614) fund and Sigrid Juselius Foundation. HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712), Swedish State Support for Clinical Research (#ALFGBG-720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862), and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017-00915), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615), the Swedish Alzheimer Foundation (#AF-742881), Hjärnfonden, Sweden (#FO2017-0243), the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236).; Lukkarinen , H , Tesseur , I , Pemberton , D , Van der Ark , P , Timmers , M , Slemmon , R , Janssens , L , Streffer , J , Van Nueten , L , Bottelbergs , A , Rauramaa , T , Koivisto , A M , Herukka , S-K , Korhonen , V E , Junkkari , A , Hiltunen , M , Engelborghs , S , Blennow , K , Zetterberg , H , Kolb , H C & Leinonen , V 2021 , ' Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus ' , Journal of Alzheimer's Disease , vol. 80 , no. 4 , pp. 1629-1642 . https://doi.org/10.3233/JAD-201361Test; http://hdl.handle.net/10138/331743Test; b44c09e8-f378-4b9d-b8d0-f55a3cdd882b; 000642444400027

  5. 5
    دورية أكاديمية

    المصدر: Salvadore , G , Bonaventure , P , Shekhar , A , Johnson , P L , Lord , B , Shireman , B T , Lebold , T P , Nepomuceno , D , Dugovic , C , Brooks , S , Zuiker , R , Bleys , C , Tatikola , K , Remmerie , B , Jacobs , G E , Schruers , K , Moyer , J , Nash , A , Van Nueten , L G M & Drevets , W C 2020 , ' Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 ....

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية